Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

A model for predicting the evolution of the Omicron wave

Scientists forecast the temporal evolution of the Omicron wave according to a susceptible-infectious-recovered/removed epidemic compartment model.

3 Mar 2022

Biden pledges better nursing home care, but he likely won’t fast-track it

President Joe Biden's top Medicare official suggested Wednesday that forthcoming rules to bolster nursing home staffing won't be issued under a4 mechanism, known as interim final rules, that would allow regulations to take effect more or less immediately.

3 Mar 2022

Scientists find no connection between pandemic chilblains and SARS-CoV-2 infection

A recent study provides a better understanding of whether SARS-CoV-2 infection is linked with the occurrence of chilblains.

3 Mar 2022

Research uncovers a new molecular interaction mechanism for SARS-CoV2

The virus causing the current COVID-19 pandemic is the SARS-CoV-2. Soon after the pandemic outbreak in 2019, the ACE-2 protein, which is present on some of our cells´ surface, was identified as the receptor facilitating host cell viral entry.

3 Mar 2022

Drug overdose death rates among Black Americans surpass that of whites for first time in 20 years

In 2020, the first year of the COVID-19 pandemic, the rate of drug overdose deaths among Black Americans surpassed that of whites for the first time since 1999 -; a sharp reversal of the situation a decade earlier, when rates were twice as high for whites as for Blacks, new UCLA research shows.

2 Mar 2022

Exposure to more green space during the pandemic linked to less depression and anxiety

People exposed to more green space during the first year of the COVID-19 pandemic reported significantly less depression and anxiety, according to new University of Colorado Boulder research published March 2 in the journal PLOS One.

2 Mar 2022

Sugar-decorated proteins in mucus could prevent SARS-CoV-2 viruses from spreading from surfaces

Early in the pandemic, many people fastidiously disinfected surfaces because laboratory studies predicted that SARS-CoV-2 could be easily transmitted in this way.

2 Mar 2022

Covid expert joins exodus into business, where science parlays into profits

Millions of free covid-19 rapid tests arriving in Americans' mailboxes are long-awaited vindication for Dr. Michael Mina, who, as a Harvard assistant professor, had been advocating for two years that the best way to limit covid is to identify it quickly, cheaply, and widely with rapid antigen tests so infected people know to isolate themselves.

2 Mar 2022

How effective is mRNA vaccination in multiple myeloma patients?

In a new study, researchers have been investigating the protection offered by the SARS-CoV-2 vaccine in patients suffering from multiple myeloma.

2 Mar 2022

Study focuses on the potential indirect effects of COVID-19 on tinnitus severity

Tinnitus, most often described as "ringing" in the ears even though no external sound is present, also can be perceived as humming, hissing, buzzing or roaring sounds.

2 Mar 2022

To be one in a million: ‘Who thinks it’s going to be you?’

Monica Melkonian wanted the Johnson & Johnson covid vaccine. It was only one shot and then she would be protected against the virus. So she was thrilled when the vaccination clinic at the Deschutes County Fair & Expo Center on April 7 had her first choice.

2 Mar 2022

Dual therapeutic potential of zapnometinib against COVID-19

Researchers assessed the impact of the drug zapnometinib on human immune response against coronavirus disease 2019.

2 Mar 2022

Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

A new study describes the efficacy of adenosine receptor agonists in the treatment of SARS-CoV-2 infection.

2 Mar 2022

The prevalence of SARS-CoV-2 in environment and animal samples from the Huanan seafood market

A new study describes the surveillance of SARS-CoV-2 within the Huanan seafood market.

2 Mar 2022

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

A new study identifies the antigenic differences that exist between the Omicron BA.2 and BA.1 variants.

2 Mar 2022

Short-term change of depressive and anxiety symptoms in relation to COVID-19 vaccination

Researchers assess the short-term impacts of vaccination on the mental health of Swedish adults, with a primary focus on depression and anxiety.

2 Mar 2022

Potential of a SARS-CoV-2 immunoPET approach to study COVID-19 dynamics in total body in rhesus macaques

In a recent study an immunoPET technique that the authors were using to analyze SIV was adapted to evaluate the spatiotemporal dynamics of SARS-CoV-2 infection in a rhesus macaque model.

2 Mar 2022

UK's bilateral donation of 1 million vaccine doses will reinforce Bangladesh’s fight against COVID-19

The UK bilaterally donated 1 million doses of the Oxford-AstraZeneca vaccine to Bangladesh. The vaccine consignment arrived in Bangladesh on 23 February 2022.

2 Mar 2022

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

The current study discusses a reliable ELISA that can detect three isotypes of antibody against three SARS-CoV-2 antigens.

2 Mar 2022

Government invests £260 million to support health research and life sciences manufacturing

Patients across the country are set to benefit from cutting-edge medical advances and treatments as the government invests £260 million today (Wednesday 2 March) to support research and development, as well as the manufacturing of new drugs, devices and diagnostics.

2 Mar 2022

Pandemic News and Research

Further Reading

A model for predicting the evolution of the Omicron wave

Biden pledges better nursing home care, but he likely won’t fast-track it

Scientists find no connection between pandemic chilblains and SARS-CoV-2 infection

Research uncovers a new molecular interaction mechanism for SARS-CoV2

Drug overdose death rates among Black Americans surpass that of whites for first time in 20 years

Exposure to more green space during the pandemic linked to less depression and anxiety

Sugar-decorated proteins in mucus could prevent SARS-CoV-2 viruses from spreading from surfaces

Covid expert joins exodus into business, where science parlays into profits

How effective is mRNA vaccination in multiple myeloma patients?

Study focuses on the potential indirect effects of COVID-19 on tinnitus severity

To be one in a million: ‘Who thinks it’s going to be you?’

Dual therapeutic potential of zapnometinib against COVID-19

Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

The prevalence of SARS-CoV-2 in environment and animal samples from the Huanan seafood market

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

Short-term change of depressive and anxiety symptoms in relation to COVID-19 vaccination

Potential of a SARS-CoV-2 immunoPET approach to study COVID-19 dynamics in total body in rhesus macaques

UK's bilateral donation of 1 million vaccine doses will reinforce Bangladesh’s fight against COVID-19

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

Government invests £260 million to support health research and life sciences manufacturing

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News